Home » Posts tagged 'patents' (Page 16)

patents

Role of intellectual property in the UK: do smaller firms benefit?

Mark Rogers (Harris Manchester College, Oxford University) focuses on applied analysis of intellectual property and performance in his research.   He is an IP Osgoode Research Affiliate. The role of IP in the UK, as elsewhere, is under active debate. In 2006 the Gowers Review of IP looked at all aspects of IP, although with a particular […]

Patent Cures, Not Genes, Cancer Patients Argue: Easier Said Than Done

Australia is now at the centre of the global gene patent debate with a Senate inquiry that began last week in Melbourne. Senators in Australia began hearing public submissions on August 4th about the topic of gene patents in relation to the impact they have on health care costs. The inquiry centres around a bid […]

The Efficacy Standard - India's New Patentability Criteria

Nigel D'Souza is a JD Candidate at Osgoode Hall Law School. I have been researching at Human Rights Law Network for over a month now and my findings are quite concerning. In terms of patent law, a skeleton based on international standards is in place but clarity is lacking. As mentioned in my previous post, […]

Patent Prosecution as Part of Business Models?

On Monday, July 13th, Mosaid Technologies Inc. filed a suit against IBM Corporation for patent infringement concerning six of Mosaid's United States patents. The suit was filed in the United States District Court in the District of Delaware. Mosaid, an Ottawa-based company, is well known for developing semiconductor technology. The patents involved in the suit […]

Public Interest Litigation to Prevent GM Seeds in India

Jasdeep Bal is a JD candidate at Osgoode Hall Law School. The Human Rights Law Network (where I am summer interning) utilizes public interest litigation (PIL) as their primary weapon to fight for human rights. The People's Patent Group, under the umbrella of HRLN, is not a priority, however, as HRLN seems to have their hands […]

Academic Perspectives on Issues Raised in the Bilski Case

On June 1st the Supreme Court of the United States granted a petition to hear the case of Bilski v. Doll. At the Court of Appeals for the Federal Circuit, the Bilski patent for a method of hedging risk in commodities trading was rejected, affirming the decision of the USPTO. The majority of the court moved away from the […]

Does Qualcomm's Value Chain Licensing System Survive Its Settlement With Broadcom? (Part Two)

Sean O'Connor is a Professor at the University of Washington School of Law and Chair of the Law, Technology & Arts Group, specializing in intellectual property and business law involving biotechnology, cyberspace/information technology, and new media/digital arts.  Professor O'Connor is an IP Osgoode Research Affiliate. This is the second part of Professor O'Connor's feature blog […]

Does Qualcomm's Value Chain Licensing System Survive Its Settlement With Broadcom? (Part One)

Sean O'Connor is a Professor at the University of Washington School of Law and Chair of the Law, Technology & Arts Group, specializing in intellectual property and business law involving biotechnology, cyberspace/information technology, and new media/digital arts.  Professor O'Connor is an IP Osgoode Research Affiliate. Qualcomm and Broadcom finally seem to have ended their long […]

United States Doctrine of Inequitable Conduct Under Scrutiny Again

The controversial doctrine of inequitable conduct has once again garnered much attention in the patent law community due to the recent denial of certiorari by the US Supreme Court in Aventis Pharma v. Amphastar.  The doctrine of inequitable conduct allows courts to exercise equitable discretion to find a patent unenforceable if the applicant has failed to exercise his or […]